Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02529748 · ClinicalTrials.gov registry record · NA

Pilot Study to Assess the Quantitative Dermal Transfer Efficiencies of Solids for Multiple Transfer Pathways

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT02529748: Completed NA study, sponsored by University of Minnesota.

NCT02529748 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02529748, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Dermal transfer efficiency has been defined as the amount of material that moves from one surface to another following contact. The investigators propose to measure dermal transfer efficiency for the following pathways: (1) object to skin, (2) skin to skin, (3) skin to mouth, (4) clothing to skin, (5) gloves to skin, and (6) air to skin. First, the quantitative dermal transfer will be measured for the two selected test substances (lead, Tinopal) for each of these six pathways. The relative quantities of dermal transfer will also then be compared between the different transfer pathways (e.g., is skin to skin transfer greater or less than clothing to skin transfer?). And second, the pattern of transfer will be characterized semi-quantitatively (e.g., does dermal transfer occur consistently and evenly to the skin from different reservoirs?).

Primary Outcome

Participants will handle or touch the approved test substances or an intermediate transfer material such as a solid surface or clothing. Surface skin wipe sampling will then be conducted to measure the amount of material that has been transferred to or from the skin surface.

Interventions

  • OTHER Participants for Surface Skin Sampling
  • OTHER Elemental metallic lead
  • OTHER Tinopal

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2015-08-01
Est. Completion 2019-07-31
Phase NA
University of Minnesota

966 total trials

What the finished NCT02529748 record still lists

NCT02529748 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Participants for Surface Skin Sampling is the first listed.

NCT02529748 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02529748 about?

NCT02529748 is a clinical study titled "Pilot Study to Assess the Quantitative Dermal Transfer Efficiencies of Solids for Multiple Transfer Pathways". Dermal transfer efficiency has been defined as the amount of material that moves from one surface to another following contact. The investigators propose to measure dermal transfer efficiency for the following pathways: (1) object to skin, (2) skin to skin, (3) skin to mouth, (4) clothing to skin, (...

What is the current status of trial NCT02529748?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2015-08-01. Estimated completion is 2019-07-31.

What interventions are being tested in trial NCT02529748?

The interventions under investigation include: Participants for Surface Skin Sampling (OTHER), Elemental metallic lead (OTHER), Tinopal (OTHER).

Who is sponsoring clinical trial NCT02529748?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02529748's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02529748, the US trial registry maintained by the National Library of Medicine. NCT02529748 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.